Hypertension in dialysis patients: a consensus document by the European Renal and Cardiovascular Medicine (EURECA-m) working group of the European Renal Association–European Dialysis and Transplant Association (ERA-EDTA) and the Hypertension and the Kidney working group of the European Society of Hypertension (ESH)*
Pantelis Sarafidis(Ippokrateio General Hospital of Thessaloniki), Carmine Zoccali(Biogem), Patrick Rossignol(Inserm), Mehmet Kanbay(Koç University), Francesca Mallamaci(Società Italiana di Nefrologia), Michel Jadoul(Cliniques Universitaires Saint-Luc), Luís M. Ruilope(Bayer (Germany)), Gérard M. London(Unknown), Alexandre Persu(Cliniques Universitaires Saint-Luc), Patrick B. Mark(Queen Elizabeth University Hospital), Andrzej Więcek(Medical University of Silesia), Patricia Van der Niepen(Universitair Ziekenhuis Brussel), Charles J. Ferro(Queen Elizabeth Hospital Birmingham), Rajiv Agarwal(Richard L. Roudebush VA Medical Center), Alberto Ortíz(Universidad Pontificia de Salamanca), F. Jarraya(University of Sfax), Marianne C. Verhaar(Utrecht University), Jean‐Michel Halimi(Université de Tours), Michel Burnier(Gdańsk Medical University), Roberto Pontremoli(Ospedale Policlinico San Martino), Raymond Vanholder(Ghent University Hospital), Grégoire Wuerzner(University of Lausanne), Gunnar H. Heine(Agaplesion Markus Hospital), Peter de Leeuw, Gianfranco Parati(IRCCS Istituto Auxologico Italiano)
Cited by 225
Related Papers
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
|New England Journal of Medicine|2019|6k
Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2020|2.6k
Obesity and Kidney Disease: Hidden Consequences of the Epidemic
|American Journal of Nephrology|2017|2.2k
2024 ESC Guidelines for the management of elevated blood pressure and hypertension
|European Heart Journal|2024|1.9k